Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting

BACKGROUND: The efficacy and safety of golimumab in elderly patients with renal dysfunction are not well evaluated due to the exclusion criteria of clinical trials. OBJECTIVE: To assess the persistence and safety of golimumab in elderly rheumatoid arthritis patients with renal dysfunction. PATIENTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Seiji, Ishii, Yutaka, Masuda, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943813/
https://www.ncbi.nlm.nih.gov/pubmed/36334249
http://dx.doi.org/10.1007/s40801-022-00338-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943813/
https://www.ncbi.nlm.nih.gov/pubmed/36334249
http://dx.doi.org/10.1007/s40801-022-00338-y

Ejemplares similares